前往化源商城

Postgraduate Medical Journal 1990-01-01

Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs.

M Ravic, A Johnston, P Turner

文献索引:Postgrad. Med. J. 66 Suppl 4 , S30-4, (1990)

全文:HTML全文

摘要

A series of studies in human subjects of potential interactions of lornoxicam with some other drugs is reviewed. No evidence of kinetic interaction was found with the antacids Maalox or Solugastrol, nor was there evidence of influence on antipyrine clearance. Lornoxicam reduced warfarin clearance and enhanced its hypoprothrombinaemic effect. It did not influence glibenclamide kinetics, but plasma insulin concentrations were significantly higher and plasma glucose concentrations significantly lower when lornoxicam and glibenclamide were co-administered. Lornoxicam produced a modest reduction in digoxin clearance, but no other clear evidence of interaction was seen. Lornoxicam significantly antagonized the diuretic and natriuretic actions of frusemide.

相关化合物

结构式 名称/CAS号 全部文献
氯诺昔康 结构式 氯诺昔康
CAS:70374-39-9